https://www.tadeclinicagem.com.br/materiais/evento-org-dzero-na-residencia-2026/
🗓️ Sábado 28/02 às 09:00 no Youtube
📍Descubra como tornar o R1 mais leve e produtivo com o D0 na Residência, evento on-line e gratuito do TdC.
Garanta agora mesmo sua vaga e receba grátis no seu e-mail:
🎁 Ebook: Sala de Emergência - 10 Temas Essenciais
🎁 Aula: Abordagem Inicial ao Paciente Grave
🎁 Aula: Drogas Vasoativas
🎁 Aula: Método Clínico
Do manejo de antibióticos à organização da rotina com IA, confira os temas que abordaremos ao vivo:
Rapha, Kaue e Fred discutem as atualizações no tratamento, diagnóstico e quadro clínico da COVID-19. Dúvidas e comentários manda pra gente no @tadeclinicagem Ou tadeclinicagem@gmail.com
Minutagem
04:00 Testes diagnósticos do COVID
04:20 PCR - swab
07:33 Quando fazer e como interpretar o resultado?
11:50 Sorologia
18:02 Teste antígeno
19:00 Tratamento do COVID
19:50 Hidroxicloroquina
24:00 Ivermectina e Anitta
26:05 Anticorpos monoclonais
27:26 Azitromicina e infecção bacteriana secundária
31:00 Ferritina / Procalcitonina
31:46 Outros cuidados do paciente ambulatorial - isolamento
34:30 Uso do PCR para sair do isolamento
36:35 Quem deve ser isolado - contactantes
38:20 Tratamento do internado: Dexametasona
43:40 Rendesivir
46:40 Anticoagulação
49:28 Imunomodulador e plasma convalescentes
50:06 Resumos das drogas do tratamento
50:33 Tratamento não farmacológico
54:30 VNI x VM
56:24 Sequelas pós-COVID
59:15 Síndrome pós UTI (PICS)
64:00 Parosmia
66:30 Salves
67:15 Resposta do desafio da semana anterior
68:08 Desafio da semana
REFERÊNCIAS:
1- https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-informs-public-about-possible-accuracy-concerns-abbott-id-now-point (Accessed on May 19, 2020).
2- DINNES, Jacqueline et al. Rapid, point‐of‐care antigen and molecular‐based tests for diagnosis of SARS‐CoV‐2 infection. Cochrane Database of Systematic Reviews, n. 8, 2020.
3- JOUNG, Julia et al. Detection of SARS-CoV-2 with SHERLOCK one-pot testing. New England Journal of Medicine, v. 383, n. 15, p. 1492-1494, 2020.
4- GUDBJARTSSON, Daniel F. et al. Humoral immune response to SARS-CoV-2 in Iceland. New England Journal of Medicine, v. 383, n. 18, p. 1724-1734, 2020.
5- HANSON, Kimberly E. et al. Infectious Diseases Society of America Guidelines on the Diagnosis of Coronavirus Disease 2019 (COVID-19): Serologic Testing. Clinical Infectious Diseases, 2020.
6-Tweeter Eric Feigl-Ding.
7- HANSON, Kimberly E. et al. Infectious Diseases Society of America guidelines on the diagnosis of COVID-19. Clinical Infectious Diseases, 2020.
8- WATSON, Jessica; WHITING, Penny F.; BRUSH, John E. Interpreting a covid-19 test result. Bmj, v. 369, 2020.
9- DEL RIO, Carlos; COLLINS, Lauren F.; MALANI, Preeti. Long-term health consequences of COVID-19. Jama, v. 324, n. 17, p. 1723-1724, 2020. 10- https://www.idsociety.org/covid-19-real-time-learning-network/disease-manifestations--complications/post-covid-syndrome/
11- RECOVERY Collaborative Group, Horby P, Lim WS, et al. Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report. N Engl J Med 2020.
12- Paranjpe I, Fuster V, Lala A, et al. Association of treatment dose anticoagulation with in-hospital survival among hospitalized patients with COVID-19. Journal of the American College of Cardiology. 2020. [In Press].
13- Spyropoulos AC, Lipardi C, Xu J, et al. Modified IMPROVE VTE Risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis. TH Open. 2020;4(1):e59-e65.
14- Horby P, Mafham M, Linsell L, et al. Effect of hydroxychloroquine in hospitalized patients with COVID-19: preliminary results from a multi-centre, randomized, controlled trial. medRxiv. 2020;Preprint.
15- Cavalcanti AB, Zampieri FG, Rosa RG, et al. Hydroxychloroquine with or without azithromycin in mild-to-moderate COVID-19. N Engl J Med. 2020.
16- Furtado RHM, Berwanger O, Fonseca HA, et al. Azithromycin in addition to standard of care versus standard of care alone in the treatment of patients admitted to the hospital with severe COVID-19 in Brazil (COALITION II): a randomised clinical trial. Lancet. 2020. Mais referências
